Landmark BioVentures AG
@landmarkbioventures.com
Landmark BioVentures is an integrative corporate and drug development company using resources smartly to advance multiple innovative therapies. Anchored by foundational science, LBV uncovers hidden gems with unrealized therapeutic potential by connecting non-obvious dots and taking a strategically-focused active hands-on approach with each nexus company. Led by a seasoned multidisciplinary team of drug developers, entrepreneurs and deal makers, LBV harnesses its specialized and industry-relevant drug development expertise and opportunistic and creative deal-making in resource-constrained environments, to streamline drug development, focusing on holistic value creation and capture.
Landmark BioVentures AG's Company Logos
Landmark BioVentures AG's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#0080A3
Deep Cerulean
0, 128, 163
193, 100, 32
100, 21, 0, 36
#92B5C7
Nepal
146, 181, 199
200, 32, 68
27, 9, 0, 22
#0E2B39
Elephant
14, 43, 57
200, 61, 14
75, 25, 0, 78
About Landmark BioVentures AG
Landmark BioVentures is a pioneering biotech building and drug development company dedicated to identifying and supporting promising science in early-stage biotech start-ups. Our unique and cost-effective model combines entrepreneurial spirit with drug development expertise, creating new ventures around patent-protected and pre-validated science, in collaboration with leading academics.
Our team of experienced co-founders brings decades of expertise in biotech, pharmaceuticals, and clinical research, with a proven track record of successful start-ups, drug development, and commercialization in oncology, immunology, and rare diseases.
We are committed to building biotech start-ups from the ground up, leveraging our extensive network and expertise to create a thriving ecosystem for innovative therapeutics. With a focus on immuno-oncology, drug discovery, and clinical development, Landmark BioVentures is at the forefront of driving progress in the biopharmaceutical industry.
Visit us at Bernouillistrasse 20, Basel, CH-4056, Switzerland to learn more about our innovative approach to biotech innovation and drug development.
